PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 74 filers reported holding PMV PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,139 | +115.3% | 2,140 | +119.5% | 0.00% | – |
| Q2 2023 | $6,104 | +67722.2% | 975 | -45.5% | 0.00% | – |
| Q1 2023 | $9 | -91.4% | 1,788 | -85.2% | 0.00% | -100.0% |
| Q4 2022 | $105 | -100.0% | 12,092 | -51.0% | 0.00% | -20.0% |
| Q3 2022 | $294,000 | +46.3% | 24,694 | +75.1% | 0.01% | 0.0% |
| Q2 2022 | $201,000 | +773.9% | 14,102 | +1199.7% | 0.01% | – |
| Q1 2022 | $23,000 | -89.7% | 1,085 | -88.8% | 0.00% | -100.0% |
| Q4 2021 | $224,000 | +113.3% | 9,680 | +173.6% | 0.00% | +33.3% |
| Q3 2021 | $105,000 | +200.0% | 3,538 | +241.8% | 0.00% | +200.0% |
| Q2 2021 | $35,000 | -61.5% | 1,035 | -62.7% | 0.00% | -50.0% |
| Q1 2021 | $91,000 | +237.0% | 2,772 | +531.4% | 0.00% | +100.0% |
| Q4 2020 | $27,000 | – | 439 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |